More Treatments for All People More Quickly
We conduct research and support activities that address long-standing challenges in translational research so that new treatments and other health solutions reach people faster.
Latest News
Read our latest research news or follow coverage of our translational science activities through national and local media.
New Path for a Gene Therapy Trial at NIH for a Rare Metabolic Disease
November 19, 2024 - NCATS News
- Bespoke Gene Therapy Consortium (BGTC)
- Our Impact on Clinical Trials
- Our Impact on Drug Discovery and Development
- Our Impact on Rare Diseases
- Platform Vector Gene Therapy (PaVe-GT)
Scientists at NCATS and other NIH institutes and centers are teaming up to advance a gene therapy treatment for MMA, a rare and potentially life-threatening genetic disorder.
Read ArticleSpectradyne: SBIR Funding Spurs Advances in Nanoparticle Technology
November 19, 2024 - NCATS News
- Small Business (SBIR)
NCATS small business innovation research funding helped Spectradyne, LLC, commercialize an improved nanoparticle analyzer critical to research and drug development.
Easing the Burden of Rare Diseases Through Translational Science
November 12, 2024 - NCATS News
- Our Impact on Rare Diseases
NCATS Director Joni Rutter discusses how NCATS is addressing scientific and operational roadblocks that slow progress for rare diseases research and treatments.
New FDA Designations May Jumpstart Gene Therapy Development
October 18, 2024 - NCATS News
- Bespoke Gene Therapy Consortium (BGTC)
- Platform Vector Gene Therapy (PaVe-GT)
New FDA designations granted to NCATS for rare disease therapies provide financial incentives for companies to further develop treatments.
Advancing Translational Science
Our Impact
Learn how our work speeds research and improves health. Key areas include big data, clinical trials and rare diseases.
Research Activities
Explore our research labs, projects and collaborations that are advancing translational science. Our largest program is the Clinical and Translational Science Awards (CTSA) Program.
Training & Education
Enhance your knowledge of translational science through programs, activities and resources offered by NCATS and our partner institutions.
Resources for You
Whether you're a researcher, an aspiring translational scientist or an interested member of the community, find information and materials important to you.
For Researchers
Learn about our latest opportunities for funding and collaboration and connect with our staff.
For Trainees
Learn about the resources and support available to help you grow as a translational scientist.
For Patients and Advocates
Learn about the patient-focused research and resources available through NCATS and NIH.
Director's Corner
Joni L. Rutter, Ph.D.
Easing the Burden of Rare Diseases Through Translational Science
November 12, 2024
NCATS Director Joni Rutter kicks off a new message series on progress and priorities in rare diseases research across the translational pipeline.
About the NCATS Director
Joni L. Rutter, Ph.D., is the director of NCATS at NIH. Rutter oversees the planning and execution of NCATS complex, multifaceted programs.
Previous Director's Messages
Search all Director's Messages by topic and year.
Subscribe to NCATS’ Community Update
Sign up to receive email messages from Dr. Rutter on center initiatives, input opportunities, events and other activities.